Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization …
Objectives. The aims of this study were to examine disease activity by the Paediatric
Rheumatology International Trials Organization (PRINTO) criteria for inactive disease and …
Rheumatology International Trials Organization (PRINTO) criteria for inactive disease and …
Aerobic exercise capacity in patients with juvenile dermatomyositis.
T Takken, N Spermon, PJM Helders… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To examine the feasibility of maximum exercise testing in patients with juvenile
dermatomyositis (JDM), characterize the maximum oxygen consumption (VO2peak) of these …
dermatomyositis (JDM), characterize the maximum oxygen consumption (VO2peak) of these …
Quality of life in adults with juvenile‐onset dermatomyositis: a case–control study
Objective To compare quality of life in adults diagnosed with juvenile dermatomyositis (DM)
with that of matched controls, and to analyze the association with other disease parameters …
with that of matched controls, and to analyze the association with other disease parameters …
The family impact of caring for a child with juvenile dermatomyositis
S Kountz-Edwards, C Aoki, C Gannon… - Chronic …, 2017 - journals.sagepub.com
Background Juvenile dermatomyositis (JDM), a rare autoimmune disease, accounts for
more than 80% of idiopathic inflammatory myopathy childhood cases, making it the most …
more than 80% of idiopathic inflammatory myopathy childhood cases, making it the most …
Physical exercise as a treatment for adult and juvenile myositis
H Alexanderson - Journal of internal medicine, 2016 - Wiley Online Library
There is growing evidence to support the safety and efficacy of exercise in patients with adult
and juvenile idiopathic inflammatory myopathies. Five randomized controlled trials including …
and juvenile idiopathic inflammatory myopathies. Five randomized controlled trials including …
Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures
BN Witczak, J Bollerslev, K Godang, T Schwartz… - …, 2022 - academic.oup.com
Objective To compare body composition parameters in patients with long-standing JDM and
controls and to explore associations between body composition and disease …
controls and to explore associations between body composition and disease …
Clinical assessment in juvenile dermatomyositis
Juvenile dermatomyositis (JDM) is a multisystem inflammatory disease of unknown etiology
that affects primarily the skin and muscles. Although the prognosis of JDM has improved …
that affects primarily the skin and muscles. Although the prognosis of JDM has improved …
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis
AM Huber, EM Dugan, PA Lachenbruch… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new
tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore …
tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore …
Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus …
AM Huber, EH Giannini, SL Bowyer… - Arthritis Care & …, 2010 - Wiley Online Library
Objective To use juvenile dermatomyositis (DM) survey data and expert opinion to develop a
small number of consensus treatment protocols, which reflect current initial treatment of …
small number of consensus treatment protocols, which reflect current initial treatment of …
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.
LM Pachman, JR Hayford, A Chung… - The Journal of …, 1998 - europepmc.org
Objective To evaluate demographic and clinical characteristics, duration of time between
disease onset (date of first rash and/or weakness), and diagnosis/therapy, as well as …
disease onset (date of first rash and/or weakness), and diagnosis/therapy, as well as …